Science Explorer Interactive view Map
Company · Abingdon · United Kingdom

PsiOxus Therapeutics (United Kingdom)

psioxus.comROR OpenAlex
Research works
40
▲ 33% vs 2013–17
Citations
1.1k
27.7 per fractional work
Top-10% rate
12.6%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: PsiOxus Therapeutics (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 9.52× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 6.17× its world share, 1 worksImmunology and Micro…Neuroscience: 0.61× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.69× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.08× its world share, 0 worksChemistryEngineering: 0.10× its world share, 0 worksEngineeringPhysics and Astronomy: 0.19× its world share, 0 worksPhysics and AstronomyMedicine: 1.96× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 9.5×. Every wedge is a field page.

Who are the top researchers at PsiOxus Therapeutics (United Kingdom)?

Ranked on the composite score, Brian Champion lead among researchers whose main affiliation is PsiOxus Therapeutics (United Kingdom).

  1. 1 Brian Champion United Kingdom · #913,800 worldwide 43 citations · 31 works
All ranked researchers at PsiOxus Therapeutics (United Kingdom)

Which keywords describe research at PsiOxus Therapeutics (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immunotherapy, Tumor Regression, AAV, Viral Vectors, Cancer Immunotherapy, CAR T Cells and Chimeric Antigen Receptor.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Gene Therapy15▲ 143×3 topics
  2. Immunotherapy12▲ 46×8 topics
  3. Tumor Regression12▲ 329×2 topics
  4. AAV8▲ 320×1 topic
  5. Viral Vectors8▲ 320×1 topic
  6. Cancer Immunotherapy7▲ 130×3 topics
  7. CAR T Cells6▲ 352×1 topic
  8. Chimeric Antigen Receptor6▲ 352×1 topic
  9. Tumor Targeting6▲ 104×2 topics
  10. Arginine Deprivation5▲ 306×1 topic
  11. Bacterial Therapy5▲ 306×1 topic
  12. Glycosylation3▲ 39×2 topics
  13. Cancer3▲ 5.7×13 topics
  14. Monoclonal Antibody3▲ 95×2 topics
  15. Mammalian Cells3▲ 167×1 topic
  16. Recombinant Protein3▲ 167×1 topic
  17. Inflammation2▲ 2.5×12 topics
  18. Biogenesis2▲ 48×3 topics
  19. Epidemiology2▲ 1.35×12 topics
  20. Biomarkers2▲ 8.4×3 topics
  21. Gene Silencing2▲ 33×2 topics
  22. RNA Interference1▲ 32×1 topic
  23. siRNA Delivery1▲ 47×1 topic
  24. Drug Delivery1▲ 7.0×2 topics
  25. Exosomes1▲ 117×1 topic
  26. Extracellular Vesicles1▲ 117×1 topic
  27. Treatment1▲ 2.5×4 topics
  28. Immunity1▲ 8.9×3 topics
  29. Antigen Presentation1▲ 28×2 topics
  30. Asthma1▲ 21×2 topics
  31. Genetics1▲ 3.7×3 topics
  32. Immunology1▲ 23×2 topics
  33. Innate Immunity1▲ 7.8×3 topics
  34. Allergic Diseases1▲ 33×1 topic
  35. Eosinophils1▲ 33×1 topic

Which research topics does PsiOxus Therapeutics (United Kingdom) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Virus-based gene therapy research, Viral Infectious Diseases and Gene Expression in Insects and Monoclonal and Polyclonal Antibodies Research.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksVirus-based gene therapy…2Virus-based gene therapy research: 2 fractional worksViral Infectious Diseases and Gene Expression in Insects: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksExtracellular vesicles i…1Extracellular vesicles in disease: 1 fractional worksImmunotherapy and Immune Responses: 0 fractional worksCancer Research and Treatments: 0 fractional worksMicroRNA in disease regulation: 0 fractional worksReceptor Mechanisms and Signaling: 0 fractional worksCell Adhesion Molecules Research: 0 fractional works
OncologyGeneticsMolecular BiologyRadiology, Nuclear Medicine and Imaging4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Virus-based gene therapy research Genetics 2 works
  3. 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Extracellular vesicles in disease Molecular Biology 1 works
  6. 6 Immunotherapy and Immune Responses Immunology 0 works
  7. 7 Cancer Research and Treatments Biotechnology 0 works
  8. 8 MicroRNA in disease regulation Cancer Research 0 works
  9. 9 Receptor Mechanisms and Signaling Molecular Biology 0 works
  10. 10 Cell Adhesion Molecules Research Immunology and Allergy 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.8%not open47.2%

World: 28% of research is openly available.

with international co-authors43.3%domestic only56.7%

World: 19% is written across borders.

How has PsiOxus Therapeutics (United Kingdom)'s research output changed?

Output in 2018–2022 was 33% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Abingdon

All research institutions in Abingdon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.